Functional Brands Inc. (NASDAQ:MEHA) Short Interest Down 37.9% in May

Functional Brands Inc. (NASDAQ:MEHA) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totaling 638,792 shares, a drop of 37.9% from the April 30th total of 1,028,286 shares. Based on an average daily volume of 93,845,172 shares, the short-interest ratio is currently 0.0 days. Approximately 2.9% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of Functional Brands from a “sell (e-)” rating to a “sell (e)” rating in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Hedge Funds Weigh In On Functional Brands

A hedge fund recently bought a new stake in Functional Brands stock. Jane Street Group LLC acquired a new position in Functional Brands Inc. (NASDAQ:MEHA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 194,968 shares of the company’s stock, valued at approximately $37,000. Jane Street Group LLC owned about 1.19% of Functional Brands as of its most recent SEC filing.

Functional Brands Stock Down 16.9%

Shares of NASDAQ MEHA opened at $0.07 on Wednesday. Functional Brands has a twelve month low of $0.06 and a twelve month high of $8.00. The stock has a market cap of $1.51 million and a price-to-earnings ratio of -0.22. The stock has a 50 day moving average price of $0.12. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.64 and a current ratio of 1.20.

Functional Brands (NASDAQ:MEHA) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.36) earnings per share for the quarter. The company had revenue of $1.65 million for the quarter.

About Functional Brands

Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products.